Skip to main content

Table 5 The pathological T stage for tumors of included studies

From: Systematic review and meta-analysis of the prognostic significance of microRNAs related to metastatic and EMT process among prostate cancer patients

Author (year)

miRNA

Expression level

Clinicopathological details

Pathological/clinical Stagea

p-value

 ≤ pT2

 ≥ pT3

Bucay (2017)

miR-3622a

Low

68

22

1.000

High

16

1

Colden (2017)

miR-466

Low

40

3

< 0.0001

High

13

22

Du (2017)

miR-543

Low

18a

4a

< 0.001

High

6a

14a

Fu (2016)

miR-132

Low

13

4

1.000

High

31

9

Fu (2016)

miR-212

Low

23

3

0.063

High

21

10

Jiang (2016)

miR-503

Low

27

14

0.03

High

35

5

Nam (2016)

miR-301a

Low

189

103

0.2968

High

175

118

Saini (2010)

miR-203

Low

9

2

 

High

10

1

Wang (2015)

miR-573

Low

30a

11a

0.003

High

18a

23a

Wang (2017)

miR-802

Low

10

17

0.02

High

30

16

Zhang (2018)

miR-410-3p

Low

29a

11a

0.003

High

17a

23a

  1. aclinical tumor stage